EFFECTS OF ACUTE VALPROATE ADMINISTRATION ON CARNITINE METABOLISM IN MOUSE SERUM AND TISSUES

被引:19
作者
ROZAS, I
CAMINA, MF
PAZ, JM
ALONSO, C
CASTROGAGO, M
RODRIGUEZSEGADE, S
机构
[1] UNIV SANTIAGO DE COMPOSTELA,FAC PHARM,DEPT BIOCHEM,SANTIAGO,SPAIN
[2] UNIV SANTIAGO DE COMPOSTELA,HOSP GEN GALICIA,SERV LAB CENT,SANTIAGO,SPAIN
关键词
D O I
10.1016/0006-2952(90)90663-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carnitine concentrations in serum, liver, kidney, muscle and heart were determined 30 min, 2 hr and 4 hr after administration of single 50 mg/kg doses of valproic acid (VPA) or octanoic acid (OTA) of fasting mice. Half an hour post-administration (p.a.) of VPA, free carnitine concentrations were smaller than in controls in serum, liver, kidney and heart. Four hr p.a., the effects of VPA had disappeared from all the carnitine sources, which now had concentrations that were not significantly different from those of controls. The effects of OTA are different from, and sometimes the opposite of, those of VPA, showing that the effects of VPA are specific to it. Hyperammonemia, on the other hand, was greatest 4 hr p.a. of VPA. These findings show that the effect of VPA on carnitine metabolism is immediate but transient, and accordingly suggest that the carnitine deficiency observed in patients under prolonged treatment with VPA-containing anticonvulsants must be due to a more complex mechanism than direct interaction between carnitine and VPA. © 1989.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 30 条
[1]   INFLUENCE OF VALPROIC ACID ON HEPATIC CARBOHYDRATE AND LIPID-METABOLISM [J].
BECKER, CM ;
HARRIS, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 223 (02) :381-392
[2]  
BOHAN TP, 1984, ANN NEUROL, V16, P394
[3]   DECREASED SERUM CARNITINE IN VALPROATE INDUCED REYE SYNDROME [J].
BOHLES, H ;
RICHTER, K ;
WAGNERTHIESSEN, E ;
SCHAFER, H .
EUROPEAN JOURNAL OF PEDIATRICS, 1982, 139 (03) :185-186
[4]   HYPERAMMONEMIA WITH VALPROIC ACID THERAPY [J].
COULTER, DL ;
ALLEN, RJ .
JOURNAL OF PEDIATRICS, 1981, 99 (02) :317-319
[5]  
COULTER DL, 1984, LANCET, V1, P689
[6]  
DIDONATO S, 1984, CLIN CHIM ACTA, V139, P12
[7]  
GERBER N, 1979, J PEDIATR, V95, P143
[8]   CHRONIC VALPROIC ACID THERAPY AND INCIDENCE OF INCREASES IN VENOUS PLASMA AMMONIA [J].
HAIDUKEWYCH, D ;
JOHN, G ;
ZIELINSKI, JJ ;
RODIN, EA .
THERAPEUTIC DRUG MONITORING, 1985, 7 (03) :290-294
[9]   THE HEPATOTOXICITY OF VALPROIC ACID AND ITS METABOLITES IN RATS .1. TOXICOLOGIC, BIOCHEMICAL AND HISTOPATHOLOGIC STUDIES [J].
KESTERSON, JW ;
GRANNEMAN, GR ;
MACHINIST, JM .
HEPATOLOGY, 1984, 4 (06) :1143-1152
[10]   SERUM CARNITINE DURING VALPROIC ACID THERAPY [J].
LAUB, MC ;
PAETZKEBRUNNER, I ;
JAEGER, G .
EPILEPSIA, 1986, 27 (05) :559-562